To reduce the incidence and mortality of cervical cancer caused by human papillomavirus (HPV) infection by helping establish routine use of effective HPV-DNA screening tests in countries with high burdens of disease.. This project was identified by RTI International for their own research purposes and some fields do not align with The GO Map categories. End dates were estimated as one year after the start date. The Project Type "Research, Clinical" may not accurately describe this project's focus but was used for all RTI International's Global Noncommunicable Diseases Initiative projects added in June 2018. Specialties were not analyzed. All project funding was valued in 2015 USD.